Tolerability Profile
ZYRTEC® provides symptom relief that’s generally well tolerated1
In clinical trials of children ages 6 to 11 years
- 4.2% of patients taking ZYRTEC® 10 mg reported somnolence (n=215) vs 1.3% with placebo (n=309)1
- ≤1% of ZYRTEC® patients discontinued due to somnolence1
Learn more about Children's ZYRTEC®
Patient resources for allergy care
Get patient information, counseling tools, plus the ZYRTEC® ALLERGYCAST® app.*
*Standard data rates apply.
Caregiver Brochure
Help educate children and caregivers about allergies with an educational brochure and storybook.
